Text Size
31 studies found for:    " November 11, 2009":" December 11, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
" November 11, 2009":" December 11, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (31 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Active, not recruiting HIV Persistence and Viral Reservoirs
Conditions: HIV;   HIV Infections
Intervention: Drug: Raltegravir, tenofovir/emtricitabine
2 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
3 Completed TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278
Condition: HIV Infections
Intervention: Drug: TMC278 (Rilpivirine) LA; Placebo
4 Recruiting A Spanish-Language Intervention to Enhance Routine HIV Patient Care Delivery [CARE+ Spanish]
Condition: HIV Infections
Interventions: Other: CARE+ Spanish computer counseling session;   Other: CARE+ Spanish brief computer risk assessment session
5 Recruiting Computerized Counseling to Promote Positive Prevention and HIV Health in Kenya
Condition: HIV Infections
Interventions: Other: CARE+ Kenya brief computer risk assessment session;   Other: CARE+ Kenya computer counseling session
6 Unknown † HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone)
Condition: HIV Infections
Interventions: Drug: Pioglitazone;   Other: Observation
7 Completed Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults
Conditions: Tuberculosis;   HIV Infections
Interventions: Biological: AERAS-402;   Biological: Placebo Control
8 Terminated Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV
Conditions: HIV Infections;   Hepatitis C Virus
Intervention:
9 Recruiting Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Conditions: HIV Infection;   Osteopenia;   Osteoporosis
Intervention:
10 Terminated Observational Study on Anti-Tat Immune Response in HIV-1-infected Asymptomatic Adult Subjects
Condition: HIV Infections
Intervention:
11 Unknown † Valacyclovir Versus Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons
Conditions: Herpes Simplex;   HIV Infection
Interventions: Drug: acyclovir;   Drug: Valacyclovir
12 Terminated Appropriate Timing of HAART in Co-infected HIV/TB Patients
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: tenofovir, lamivudine, efavirenz
13 Completed Cardiovascular Risk Evaluation and Antiretrovirals in HIV
Conditions: Cardiovascular Risk;   HIV Infections
Intervention:
14 Completed Observational Study of the Therapeutic Study of Recombinant HIV-1 TAT
Condition: HIV Infection
Intervention:
15 Completed Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients
Conditions: HIV Infection;   Rheumatic Disease;   Cancer;   Transplant;   Pediatrics
Intervention: Biological: Adjuvanted influenza A(H1N1) vaccines
16 Active, not recruiting Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients
Conditions: HIV Infection;   Liver Failure;   Evidence of Liver Transplantation
Intervention: Drug: Raltegravir potassium
17 Terminated Analysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / Ritonavir
Condition: HIV Infections
Intervention: Drug: Kaletra
18 Terminated Observational Study on Anti-tat Immune Response in HIV-1-infected HAART-treated Adult Subjects
Condition: HIV Infection
Intervention:
19 Completed A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761 formulation 1;   Drug: GSK2248761 reference formulation;   Drug: GSK2248761 formulation 3;   Drug: GSK2248761 formulation 2 or 4
20 Completed Exploration of HIV Reservoirs
Condition: HIV-1 Infection
Intervention: Procedure: Rectal mucosa biopsy
To Top

Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results
† Indicates status has not been verified in more than two years